Fortem Financial Group LLC Raises Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Fortem Financial Group LLC lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.8% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 4,263 shares of the company’s stock after acquiring an additional 115 shares during the quarter. Fortem Financial Group LLC’s holdings in HCA Healthcare were worth $1,280,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. MML Investors Services LLC boosted its stake in shares of HCA Healthcare by 31.7% during the third quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock valued at $7,241,000 after purchasing an additional 4,285 shares in the last quarter. Meritage Group LP bought a new position in shares of HCA Healthcare in the 3rd quarter worth $150,548,000. Alpha DNA Investment Management LLC bought a new position in HCA Healthcare in the third quarter worth about $869,000. NRI Wealth Management LC acquired a new stake in HCA Healthcare in the fourth quarter valued at approximately $2,896,000. Finally, Chiron Investment Management LLC acquired a new position in HCA Healthcare during the 3rd quarter valued at about $3,548,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at HCA Healthcare

In related news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on HCA. KeyCorp decreased their price objective on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a research note on Tuesday, December 17th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. Finally, Morgan Stanley dropped their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. One research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $388.60.

HCA Healthcare Price Performance

Shares of NYSE:HCA traded down $0.09 during midday trading on Monday, reaching $296.61. 854,034 shares of the company’s stock traded hands, compared to its average volume of 1,008,546. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The company has a fifty day simple moving average of $326.93 and a two-hundred day simple moving average of $354.99. The company has a market cap of $75.13 billion, a P/E ratio of 13.32, a PEG ratio of 1.21 and a beta of 1.64. HCA Healthcare, Inc. has a 1 year low of $276.50 and a 1 year high of $417.14.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.89%. The ex-dividend date of this dividend was Friday, December 13th. HCA Healthcare’s dividend payout ratio is presently 11.85%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.